L. Frigerio et al., P53 MUTATIONS APPEAR AN ACQUIRED RATHER THAN AN INHERITED EVENT IN SPORADIC OVARIAN-CANCER - A STUDY OF DNA FROM TUMOR SPECIMENS AND BLOOD LEUKOCYTES, International journal of gynecological cancer, 7(3), 1997, pp. 188-196
The p53 gene is located on the small arm of chromosome 17 and mutation
s or hyperexpression are found in a high percentage of ovarian cancer
cases (44-92%). We studied DNA extracted from blood leukocytes of 38 o
varian cancer patients; tumor tissues were also available for analysis
in 20 of these cases. Specimens were examined using Single Strand Con
formation Polymorphism (SSCP) analysis and direct genomic sequencing o
f the p53 gene. Exons from 2 to 11 were studied in blood and tumoral t
issues. Single Strand Conformation Polymorphism analysis and direct ge
nomic sequencing showed that seven patients (18.4%) had a germline alt
eration of the p53 gene, but only two of them (5.2%) led to an amino a
cid change. The other five patients had only a silent mutation which d
oes not change the amino acid (two patients) or had intronic mutations
(four patients) whose interpretation is uncertain. Somatic mutations
of the p53 gene were found in nine of the 20 tumoral tissues (45%). On
e tumor contained two mutations in the p53 gene (no. 9). Our study, th
ough preliminary and based on a small group of patients, suggests that
classic p53 mutations in sporadic ovarian cancer cases are common, bu
t they are not generally found in the germinal line.